Search for: "Price v. United States Government et al" Results 121 - 140 of 334
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 Dec 2017, 9:57 am by Wolfgang Demino
Hastings Law Journal has a new article (technically a "Note") on predatory lending and the implications of the Second Circuit's holding on federal (non)preemption of state usury laws in Saliha Madden v Midland Funding LLC et al, written by a recent graduate. [read post]
5 Nov 2017, 6:02 am by Wolfgang Demino
MADDEN136 S.Ct. 2505 (2016)MIDLAND FUNDING, LLC, et al., petitioners,v.Saliha MADDEN.No. 15-610.Supreme Court of United States.June 27, 2016.Petition for writ of certiorari to the United States Court of Appeals for the Second Circuit denied.136 S.Ct. 1484 (2016)MIDLAND FUNDING, LLC, et al., petitioners,v.Saliha MADDEN.No. 15-610.Supreme Court of United States.March 21, 2016.The Solicitor General is invited to file a brief in… [read post]
5 Nov 2017, 6:02 am by Wolfgang Demino
MADDEN136 S.Ct. 2505 (2016)MIDLAND FUNDING, LLC, et al., petitioners,v.Saliha MADDEN.No. 15-610.Supreme Court of United States.June 27, 2016.Petition for writ of certiorari to the United States Court of Appeals for the Second Circuit denied.136 S.Ct. 1484 (2016)MIDLAND FUNDING, LLC, et al., petitioners,v.Saliha MADDEN.No. 15-610.Supreme Court of United States.March 21, 2016.The Solicitor General is invited to file a brief in… [read post]
23 Oct 2017, 4:22 pm by Kevin LaCroix
The quality and integrity of corporate decision-making is constantly being tested by new rules and regulations governing corporate compliance. [read post]
23 Oct 2017, 4:22 pm by Kevin LaCroix
The quality and integrity of corporate decision-making is constantly being tested by new rules and regulations governing corporate compliance. [read post]
15 Jun 2017, 2:09 pm by Eric Caligiuri
AMGEN INC. et al., the United States Supreme Court in a unanimous opinion ruled that biosimilar makers can give their required 180-day statutory notice of sales before their products win approval by the United States Food and Drug Administration (“FDA”). [read post]
15 Jun 2017, 2:09 pm by Eric Caligiuri
AMGEN INC. et al., the United States Supreme Court in a unanimous opinion ruled that biosimilar makers can give their required 180-day statutory notice of sales before their products win approval by the United States Food and Drug Administration (“FDA”). [read post]
19 May 2017, 12:23 pm by Wolfgang Demino
  The elements of a wrongful foreclosure claim are: (1) a defect in the foreclosure-sale proceedings; (2) an inadequate selling price; and (3) a causal connection between the defect and the inadequate selling price. [read post]
17 Apr 2017, 1:26 pm
In the United States, shareholder primacy continues to define the legal standard.[15] “While many deplored the disconnect between corporate power and social need, and CSR . . . became a more frequent discussion topic in corporate and academic circles, not many corporations acted meaningfully in pursuing CSR. [read post]